Skip to main content
Clinical Trials/NCT07630766
NCT07630766CompletedNot Applicable

Comparative Study Between Noninvasive Ventilation and High Flow Nasal Cannula in Patients With High Risk of Extubation Failure

Benha University1 site in 1 country102 target enrollmentStarted: July 30, 2025Last updated:
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
102
Locations
1

Study Overview

Brief Summary

Extubation failure is associated with increased morbidity and mortality in critically ill patients. High-risk patients may benefit from preventive respiratory support after extubation. This randomized controlled trial compared noninvasive ventilation (NIV) with high-flow nasal cannula (HFNC) in adult intensive care unit (ICU) patients at high risk of extubation failure. The study evaluated reintubation rates, time to reintubation, physiological parameters, complications, and clinical outcomes following planned extubation. The aim was to determine the optimal post-extubation respiratory support strategy for reducing extubation failure in high-risk ICU patients.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Investigator, Outcomes Assessor)

Masking Description

Due to the nature of the interventions, blinding of participants and treating clinicians was not feasible. However, outcome assessors and data analysts were blinded to treatment allocation to minimize assessment bias.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥18 years.
  • Received invasive mechanical ventilation for at least 24 hours.
  • Considered ready for planned extubation after successful completion of a spontaneous breathing trial.
  • High risk of extubation failure, defined by the presence of at least four of the following risk factors:
  • Age >65 years. APACHE II score >12 on the day of extubation. Body mass index >30 kg/m². Inadequate secretion management. Difficult or prolonged weaning. Two or more comorbidities. Acute heart failure requiring mechanical ventilation. Moderate-to-severe chronic obstructive pulmonary disease. Airway patency problems. Prolonged mechanical ventilation. Hypercapnia at the end of the spontaneous breathing trial.

Exclusion Criteria

  • Age <18 years.
  • Presence of a tracheostomy.
  • Accidental extubation.
  • Self-extubation.
  • Contraindication to noninvasive ventilation.

Arms & Interventions

NIV

Experimental

Patients received noninvasive ventilation immediately after planned extubation according to the study protocol.

Intervention: NIV (Device)

HFNC

Active Comparator

Patients received high-flow nasal cannula oxygen therapy immediately after planned extubation according to the study protocol.

Intervention: HFNC (Device)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Koot Ahmad

lecturer of chest diseases

Benha University

Study Sites (1)

Loading locations...

Similar Trials